GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance

May 1, 2024 · The company raises guidance for earnings and sales for the full year. ... GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance. Zacks Equity Research . Wed, May 1, …

CouponFollow Extension

$1.09
OFF

GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance

1 week from now

May 1, 2024 · GSK plc (GSK Quick Quote GSK - Free Report) reported core earnings of $1.09 per American depositary share (“ADS”) in first- quarter 2024, beating the Zacks Consensus …

zacks.com

10%
OFF

First Quarter 2024 - GSK

1 week from now

GSK makes a strong start to 2024 with improving outlook for the year Broad-based performance drives sales, profits and earnings growth: • Total Q1 2024 sales £7.4 billion +10% and +13% …

gsk.com

16%
OFF

GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance

1 week from now

GSK plc (GSK) reported core earnings of $1.09 per American depositary share (“ADS”) in first- quarter 2024, beating the Zacks Consensus Estimate of 94 cents. Core earnings rose 16% …

reportify.cc

$1.09
OFF

GSK Stock Earnings: GSK Beats EPS, Beats Revenue For Q1 2024

1 week from now

May 1, 2024 · GSK (NYSE: GSK) just reported results for the first quarter of 2024. GSK reported earnings per share of $1.09. This was above the analyst estimate for EPS of 91 cents.

businessinsider.com

$1.09
OFF

GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance - MSN

1 week from now

GSK plc GSK reported core earnings of $1.09 per American depositary share (“ADS”) in first- quarter 2024, beating the Zacks Consensus Estimate of 94 cents. ... GSK Beats Q1 Earnings …

msn.com

$1.09
OFF

GSK Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance

1 week from now

Jul 31, 2024 · GSK Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance. Written by Zacks Equity Research for Zacks ->. GSK plc GSK reported core earnings of $1.09 per American …

nasdaq.com

$1.09
OFF

GSK Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance

1 week from now

Jul 31, 2024 · GSK plc (. GSK Quick Quote. GSK - Free Report) reported core earnings of $1.09 per American depositary share (ADS) in second-quarter 2024, beating the Zacks Consensus …

zacks.com

$800
OFF

Home | GSK US

1 week from now

November 12 2024 GSK Celebrates 2024 IMPACT Award Winners. October 24 2024 GSK invests up to $800 million in Pennsylvania site, largest manufacturing investment in U.S. October 24 …

gsk.com

28%
OFF

GSK Lifts Guidance After Turnover Beats Expectations

1 week from now

May 1, 2024 · GSK lifted its full-year guidance after first-quarter core earnings rose 28%, helped by higher sales of vaccines and specialty medicines .

wsj.com

$1.09
OFF

GSK Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance - MSN

1 week from now

GSK Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance. 1w. GSK plc GSK reported core earnings of $1.09 per American depositary share (ADS) in second-quarter 2024, beating the …

msn.com

$44502
OFF

Uber Driver Salary In Newark, New Jersey (November, 2024)

1 week from now

As of November 01, 2024, the average annual pay of Uber Driver in Newark, NJ is $44,502. While Salary.com is seeing that Uber Driver salary in Newark, NJ can go up to $63,224 or down to …

salary.com

FAQs about GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance Coupon?

How did GSK plc perform in first quarter 2024?

GSK plc GSK reported core earnings of $1.09 per American depositary share (“ADS”) in first- quarter 2024, beating the Zacks Consensus Estimate of 94 cents. Core earnings rose 16% year over year on a reported basis and 28% at a constant exchange rate (CER). ...

Does GSK make a strong start to 2024?

GSK makes a strong start to 2024 with... Vaccines sales +16%, +22% ex COVID. Shingrix £0.9 billion +18%, Arexvy £0.2 billion General Medicines sales +1%. Trelegy £0.6 billion +33% Core operating profit +27% (with further positive impact of +8% ex COVID) and Core EPS +28% (with further positive impact of +9% ex COVID). ...

Will GSK pay dividends in Q1 2024?

The Board has declared a first interim dividend for Q1 2024 of 15p per share (Q1 2023: 14p per share). Dividends remain an essential component of total shareholder return and GSK recognises the importance of dividends to shareholders. ...

How much will GSK's core operating profit grow?

Meanwhile, core operating profit—a closely watched measure of profitability—is expected to grow between 11% and 13%, up from 9% to 11% previously. For core earnings per share, GSK expects growth of 10% to 12% from 8% to 10% previously. ...

When will GSK's Q2 results be published in Illinois?

Three other cases have trial dates in Illinois ahead of the expected publication date of GSK's results for Q2 2024 (Gross and Kasza, cases alleging prostate and breast cancer, respectively on 5 June 2024 and Kimbrow, a case alleging prostate cancer, on 12 July 2024). ...

What is GSK's guidance for 2024?

GSK raised its guidance for 2024. Management expects sales to increase toward the upper end of the previously-announced guidance of 5-7% range (at CER). This upgrade comes after the company won the Zejula royalty dispute appeal and now expects royalty income to be slightly higher for the full year. ...